Free Trial

Nurix Therapeutics (NRIX) Insider Trading & Ownership

Nurix Therapeutics logo
$22.64 -0.15 (-0.66%)
(As of 11/20/2024 ET)

Nurix Therapeutics (NASDAQ:NRIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$2.22 M
Get NRIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NRIX Insider Buying and Selling by Quarter

Nurix Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2024Houte Hans VanCFOSell3,546$24.28$86,096.88  
10/30/2024Gwenn HansenInsiderSell3,437$24.30$83,519.10  
10/30/2024Houte Hans VanCFOSell2,368$24.30$57,542.40  
10/14/2024Christine RingInsiderSell3,290$25.00$82,250.00  
10/1/2024Christine RingInsiderSell5,760$22.23$128,044.80  
9/3/2024Christine RingInsiderSell9,050$24.94$225,707.00  
8/26/2024Christine RingInsiderSell9,870$25.01$246,848.70  
8/26/2024Houte Hans VanCFOSell20,000$25.22$504,400.00  
8/1/2024Christine RingInsiderSell5,760$21.43$123,436.80  
8/1/2024Houte Hans VanCFOSell3,477$21.45$74,581.65  
7/30/2024Gwenn HansenInsiderSell3,408$20.67$70,443.36  
7/30/2024Houte Hans VanCFOSell2,490$20.67$51,468.30  
7/1/2024Christine RingInsiderSell5,760$20.81$119,865.60  
6/12/2024Christine RingInsiderSell1,900$17.01$32,319.00  
6/5/2024Christine RingInsiderSell400$17.00$6,800.00  
6/3/2024Christine RingInsiderSell1,596$17.01$27,147.96  
5/2/2024Houte Hans VanCFOSell3,499$12.83$44,892.17  
4/30/2024Gwenn HansenInsiderSell2,007$12.04$24,164.28  
4/30/2024Houte Hans VanCFOSell1,387$12.04$16,699.48  
2/16/2024Houte Hans VanCFOSell6,812$10.02$68,256.24  
1/30/2024Gwenn HansenInsiderSell2,334$7.99$18,648.66  
1/30/2024Houte Hans VanCFOSell1,671$7.99$13,351.29  
12/19/2023Houte Hans VanCFOSell10,906$10.00$109,060.00  
(Data available from 1/1/2013 forward)

NRIX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Stefani Wolff. Learn more on insiders at NRIX.

9.80% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings.

The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($1,029,256.86), Gwenn Hansen ($242,813.04), Houte Hans Van ($1,061,986.86), and Stefani Wolff ($8,373.68).

Insiders have sold a total of 124,078 Nurix Therapeutics shares in the last 24 months for a total of $2,342,430.44 sold.

Nurix Therapeutics Key Executives

  • Dr. Arthur T. Sands M.D. (Age 62)
    Ph.D., CEO, President & Director
    Compensation: $986.32k
  • Mr. Johannes Van Houte (Age 58)
    Chief Financial Officer
    Compensation: $681.98k
  • Dr. Gwenn M. Hansen Ph.D. (Age 53)
    Chief Scientific Officer
    Compensation: $702.75k
  • Dr. John Kuriyan Ph.D.
    Founder & Member of Scientific Advisory Board
  • Mr. Michael Rapé Ph.D.
    Founder & Member of Scientific Advisory Board
  • Dr. Arthur Weiss M.D.
    Ph.D., Founder & Member of Scientific Advisory Board
  • Rita Kwong
    Senior Accounting Manager
  • Dr. Christine Ring J.D. (Age 59)
    Ph.D., Chief Legal Officer, Secretary & Chief Compliance Officer
    Compensation: $595.83k
  • Mr. Eric C. Schlezinger J.D. (Age 57)
    Chief People Officer
  • Dr. Jason Kantor Ph.D.
    Chief Business Officer


This page (NASDAQ:NRIX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners